Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 1.41 trillion as of March 20, 2026. Its market cap has increased by 171.26% in one year.

Market Cap

1.41T

Enterprise Value

1.38T

Revenue

1.96B

Ranking

n/a

PE Ratio

n/a

Stock Price

14,700.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 1.41T, an increase of 2,872.45%. That is a compound annual growth rate of 15.84%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	1.41T	196.07%
Dec 30, 2025	476.82B	-15.13%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1.04T	-4.44%
Dec 29, 2022	1.09T	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.34T
Celltrion	44.21T
ALTEOGEN	19.25T
Sam Chun Dang Pharm.	18.49T
L&C BIO Co.,LTD	1.87T
Daewoong Pharmaceutical	1.84T
Chabiotech	1.72T
GC Biopharma	1.66T

Market Cap Rankings